Related Experiment Video
Updated: May 22, 2026
16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
SPECT molecular imaging in Parkinson's disease
Ling Wang1, Qi Zhang, Huanbin Li
1Department of Nuclear Medicine, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China.
Journal of Biomedicine & Biotechnology
|April 25, 2012
Summary
Single-photon emission computed tomography (SPECT) aids in diagnosing Parkinson's disease (PD) early. This neuroimaging technique helps differentiate parkinsonism and monitor disease progression and treatment effectiveness.
Area of Science:
- Neurology
- Nuclear Medicine
- Medical Imaging
Background:
- Parkinson's disease (PD) diagnosis is primarily clinical, relying on motor symptoms.
- Current diagnostic accuracy for PD remains limited, especially in early stages.
- Parkinsonism presents with diverse underlying causes, necessitating accurate differential diagnosis.
Purpose of the Study:
- To evaluate the utility of SPECT in the early differential diagnosis of PD.
- To explore SPECT's potential in assessing PD pathophysiology and progression.
- To determine SPECT's role in monitoring therapeutic efficacy for PD.
Main Methods:
- Functional neuroimaging using SPECT was employed.
- Analysis focused on patients presenting with initial signs of parkinsonism.
- SPECT findings were correlated with disease characteristics and treatment responses.
Main Results:
- SPECT imaging reveals changes potentially linked to PD pathophysiology.
- Detected changes may also represent compensatory mechanisms or treatment complications.
- SPECT demonstrates potential for early detection and differentiation of parkinsonian disorders.
Conclusions:
- SPECT serves as a valuable tool for the early differential diagnosis of Parkinson's disease.
- SPECT can sensitively assess the pathophysiology and progression of PD.
- The technique holds promise for evaluating the effectiveness of PD treatments.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
01:29Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...